BioTekna
BioTekna, founded in 1996 in Marcon (Venice), develops proprietary non-invasive medical devices and the BioTekna Plus software platform for chronic inflammation, stress, body composition, and autonomic nervous system assessment. It serves medical professionals, elite athletes, and corporate executives across 17 countries.
- Company typePrivate
- Founded1996
- HeadquartersMarcon, Italy
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What BioTekna does
BioTekna is an Italian biomedical technology company founded in 1996 in Marcon (Venice) by Dario Boschiero. The company designs, manufactures, and distributes non-invasive medical devices and supporting software used to assess chronic inflammation, autonomic nervous system function, body composition, and prefrontal cortex activity. Its core product line comprises five proprietary hardware devices — TomEEX (two-dimensional tomographic bioimpedance for chronic inflammation localization), BIA-ACC (multi-frequency bioimpedance body composition analysis with HPA Axis Index), PPG Stress Flow (multi-channel plethysmograph for HRV and ANS analysis), RegMatEx (electrodermal biofeedback for chronic pain and inflammation), and HEG (prefrontal cortex plethysmography with neurofeedback) — all connected through the BioTekna Plus integrated clinical software platform. Supporting offerings include the OSO-Test diagnostic application for Osteosarcopenic Obesity Syndrome, disposable electrodes, the Melcalin nutritional supplement line, and the BioTekna Performance Platform with the portable ANS Control device for remote psychophysical monitoring.
The company serves three primary customer segments: medical professionals (general practitioners, specialists, nutritionists, sports medicine practitioners in preventive and anti-aging medicine), elite professional athletes and teams (MotoGP, Formula 1, WorldSBK, rugby, Olympic sports), and corporate executives and teams seeking performance optimization. Revenue is generated through four streams: hardware device sales (medical devices plus disposables), recurring software subscriptions via the BioTekna Plus platform, professional training and ECM-accredited education through the Open Academy of Medicine (founded 2012), and consumer food supplements. Go-to-market is primarily direct enterprise field sales supplemented by international distributor installations across 17 countries and event-driven clinical training programs.
Operationally, BioTekna is founder-owned and bootstrapped, with no disclosed institutional capital. The company reports an accumulated database of approximately 11 million physiological tests over 14 years (with roughly 2 million tests processed annually and a 20% annual growth trend), claims over 50% penetration of Italy's private preventive/anti-aging medicine market, and maintains an academic research network spanning institutions such as UCLA, Ohio State, Sapienza Rome, the University of Nottingham, the Feinstein Institute, Pennington Biomedical Research Center, and the National and Kapodistrian University of Athens. BioTekna operates through its Italian headquarters, a UK-registered entity (Biotekna Limited, London), and a Woking office tied to the McLaren Technology Group partnership.
BioTekna firmographics
Firmographics- Name
- BioTekna
- Legal name
- Biotekna Limited
- Website
- https://biotekna.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- BioTekna, founded in 1996 in Marcon (Venice), develops proprietary non-invasive medical devices and the BioTekna Plus software platform for chronic inflammation, stress, body composition, and autonomic nervous system assessment. It serves medical professionals, elite athletes, and corporate executives across 17 countries.
- Ownership category
- akta.pro rank
Where BioTekna is headquartered
LocationHeadquarters
- HQ city
- Marcon
- HQ country
- Italy
- HQ region
- Europe
Offices3 records
Markets served
BioTekna business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Medical Devices: Sale and distribution of proprietary non-invasive medical devices including TomEEx, BIA-ACC, PPG Stress Flow, RegMatEx, and HEG. Devices are sold directly to medical professionals, sports medicine practitioners, and research facilities.
- Software Platform (BioTekna Plus): Integrated software platform subscription for device connectivity, medical records management, and advanced clinical applications.
- Professional Training and Education: ECM-accredited training courses, workshops, and certification programs through Open Academy of Medicine for healthcare professionals. Courses range from single sessions to comprehensive multi-module programs.
- Food Supplements (Melcalin): Nutritional solutions sold through melcalin.com, complementing the medical devices and performance programs.
Go-to-market motion2 records
Distribution channels5 records
Marketing channels6 records
BioTekna product offering
Product offeringCore offering
BioTekna develops, manufactures, and sells proprietary non-invasive medical devices for body composition analysis, autonomic nervous system assessment, and psychophysical performance optimization. Its product portfolio centers on the BioTekna Plus software platform connecting five core hardware devices — TomEEx, BIA-ACC, PPG Stress Flow, RegMatEx, and HEG — sold primarily to medical professionals, sports medicine practitioners, and research institutions, with a Psychophysical Performance Program service for athletes and executives.
Product overview
BioTekna is a Centre of Research, Development and Excellence, leader for non-invasive medical devices for health, prevention, and performance. The company offers a unified portfolio centered on the BioTekna Plus software platform, which connects five core medical devices: TomEEX (chronic inflammation tomographic analysis), BIA-ACC (body composition clinical analysis), PPG Stress Flow (autonomic nervous system monitoring), RegMatEx (electrodermal biofeedback for pain/inflammation), and HEG (prefrontal cortex analysis). Additional offerings include the OSO-Test diagnostic application and Disposable Electrodes. The portfolio extends to psychophysical performance with the BioTekna Performance Platform and ANS Control portable device, supported by the Melcalin nutritional supplement line. Founded in 1996, BioTekna has developed technologies validated through clinical trials and published research, processing approximately 2 million tests annually across its global installations.
Differentiator
Problem solved
Functional benefit
Brands
- BioTekna Plus: Clinical, nutritional and physical mobility integrated software platform that manages all BioTekna medical devices, medical records, and advanced applications for biofeedback and nutritional analysis.
- Open Academy of Medicine
- BioTekna Performance
Products and services
- TomEEX Medical device for recognition and localization of low-grade chronic inflammatory processes using two-dimensional tomographic bioimpedance measurements. Analyzes activation state of the stress reaction system and performs extracellular bio-impedance tomographic measurement cycles. For medical professionals.
- BIA-ACC Multi-frequency bioelectrical impedance device for analysis and monitoring of body composition in quantitative, qualitative, and functional aspects. Detects TBW, ECW, ICW, FFM, FM, ECMatrix, BMR, and HPA Axis Index. For medical professionals and sports scientists.
- PPG Stress Flow Multi-channel plethysmograph device for analysis of autonomic nervous system activity and heart rate variability. Monitors Mean HR, SDNN, VLF, LF, HF power, scatter-heart rate, bilateral flow, and ANS balance. For clinicians and performance practitioners.
- RegMatEx Non-invasive electrodermal biofeedback device for reducing chronic perceived pain, systemic inflammation, and stress. Uses low-frequency polarized electromagnetic signals to modify ionic mobility and stimulate cell membrane repolarization. For medical professionals.
- HEG
- BioTekna Plus Clinical, nutritional, and physical mobility integrated software platform that connects all BioTekna medical devices, provides unified storage, standardized interface, and advanced applications for biofeedback and nutritional analysis. Processes approximately 2 million tests per year. For medical and performance professionals.
- OSO-Test Non-invasive diagnostic application for assessment of Osteosarcopenic Obesity Syndrome using BIA-ACC, PPG device, and BioTekna Plus platform. Combines muscle, bone, and fat composition analysis with stress and inflammation markers. For clinicians.
- Disposable Electrodes (Code 3034) Disposable bioimpedance, ECG, and EMG electrodes with Ag/AgCl and solid conductive gel optimized for diagnostic measurements. Compatible with BioTekna bioimpedance devices and BIA-ACC system. For clinical users.
- BioTekna Performance Platform Advanced portable technology platform for real-time performance analysis for athletes, executives, teams, and corporate activities. Combines with ANS Control for remote monitoring. For elite athletes, teams, and corporate clients.
- BioTekna ANS Control Portable device for remote performance analysis and biofeedback, enabling one-to-one and team activities with real-time monitoring capabilities. For athletes, executives, and remote performance clients.
- Melcalin Food Supplements Nutritional solutions sold through melcalin.com, complementing the medical devices and performance programs. For healthcare practitioners and end consumers.
- Open Academy of Medicine Training Programs ECM-accredited training courses, workshops, and certification programs for healthcare professionals, nutritionists, sports medicine practitioners, and executives. Founded in 2012 with international scientific faculty. For medical professionals seeking continuing education.
Quantifiable outcome
- 20% annual growth in tests collected and analyzed
- +2 more outcomes
Companies that use BioTekna
Customer profileNamed customers16 records
Segments5 records
Ideal customer profiles4 records
BioTekna technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature8 records
BioTekna partnerships and signals
Strategic signalPartnerships
18 partnerships are on record, tiered core and minor.
- Open Academy of MedicinecoreFounded by BioTekna in 2012 with distinguished international scientists and academics. A global initiative for higher education and continuing medical education. BioTekna contributes by creating and sharing scientific discoveries from multidisciplinary professionals.
- University of Regensburg, GermanycoreResearch and development collaboration with Department of Internal Medicine for clinical validation studies.
- University of Athens, GreececoreCollaboration with National and Kapodistrian University of Athens including First Dept. Pediatrics and Unit of Endocrinology for stress and inflammation research.
- The Ohio State University, Columbus, USAcoreAcademic partnership with Department of Psychology for autonomic nervous system and stress research.
- Feinstein Institute for Medical Research, NY, USAcoreResearch collaboration for medical research and clinical validation.
- University of Rome 'Sapienza', ItalycorePartnership with Department of Experimental Medicine for clinical research.
- Pennington Biomedical Research Center, LA, USAcoreCollaboration with clinical science faculty for body composition and metabolic research.
- UCLA, CA, USAcorePartnership with Gail and Gerald Oppenheimer Family Center for Neurobiology of Stress.
- University of Nottingham, UKcoreCollaboration with Division of Child Health for developmental research.
- Guy's and St Thomas' NHS Foundation Trust, London, UKcoreNHS partnership for clinical research and validation.
- University of Bologna, ItalycoreAcademic collaboration for medical research.
- AREA Science Park in Trieste, ItalycoreNational research collaboration for technology development.
- Ohio University, Athens, OH, USAminorAcademic research partnership.
- Medical University of Rijeka, Pula, CroatiaminorMedical research collaboration.
- Louisiana State University, Baton Rouge, Louisiana, USAminorAcademic research collaboration.
- McLaren Technology GroupcorePerformance technology partnership for elite motorsport and performance optimization.
- Benetton RugbycoreScientific partnership for rugby team performance optimization using BIA-ACC and PPG technologies. BioTekna serves as scientific partner with continuous monitoring and analysis programs.
- Athletic BioTekna MarconcoreAthletic development center at BioTekna headquarters for local sports performance programs.
Scale indicators7 records
Recent moves7 records
Expansion highlights5 records
BioTekna competitors and assessment
Company assessmentEmerging players
- Whoop: Whoop provides wearable HRV, recovery, and strain monitoring used by athletes and executives, an emerging consumer-grade player whose stress and recovery metrics increasingly overlap with BioTekna's performance and ANS analysis offerings.
- Biopac Systems Inc. Biopac provides research-grade physiological data acquisition systems used in academic and clinical labs for EMG, EEG, EDA, and HRV, an emerging research-tools player with overlapping instrumentation to BioTekna's TomEEX and HEG systems.
- Oura: Oura makes a smart ring that tracks HRV-based recovery, stress, and sleep, an emerging consumer wearable whose biomarker approach competes for the same preventive wellness and executive performance budget that BioTekna targets with its Performance Platform.
Direct peers
- InBody: InBody is the global reference point for medical-grade bioelectrical impedance body composition analyzers, the closest direct competitive peer to BioTekna's BIA-ACC across the same clinical and sports medicine customer base.
- HeartMath: HeartMath makes HRV-based stress management and biofeedback devices and programs, directly overlapping BioTekna's PPG Stress Flow and RegMatEx in autonomic nervous system assessment and stress reduction.
- Thought Technology Ltd. Thought Technology is a leading manufacturer of biofeedback, psychophysiological, and neurofeedback equipment used in clinical, research, and performance settings, the most direct peer to BioTekna's RegMatEx and HEG neurofeedback lines.
- Mind Media BV: Mind Media produces clinical-grade biofeedback and neurofeedback hardware and software, competing with BioTekna in the same cardiology, neurology, and applied psychophysiology channels across Europe.
Broad incumbents
- Polar Electro: Polar is a broad incumbent in HRV-driven heart rate monitors and sports performance watches, comparable to BioTekna's PPG Stress Flow and Performance Platform but focused on consumer and pro-sumer endpoints rather than clinical diagnostics.
- Tanita: Tanita is the incumbent leader in BIA body composition devices used by medical, fitness, and research professionals worldwide, broadly comparable to BioTekna's body composition offering but with much wider distribution and a consumer franchise.
- Garmin: Garmin is a broad incumbent in sports, fitness, and health wearables with HRV and Body Battery stress metrics, comparable in end-user behavior to BioTekna's Performance Platform but at very different price points and distribution.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks4 records
Key highlights7 records
Customer concentration
BioTekna social profiles
Digital presenceBioTekna financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioTekna leadership team
Management profileNumber of profiles
Profiles1 record
BioTekna funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioTekna M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioTekna
What does BioTekna do?
BioTekna develops, manufactures, and sells proprietary non-invasive medical devices for body composition analysis, autonomic nervous system assessment, and psychophysical performance optimization. Its product portfolio centers on the BioTekna Plus software platform connecting five core hardware devices — TomEEx, BIA-ACC, PPG Stress Flow, RegMatEx, and HEG — sold primarily to medical professionals, sports medicine practitioners, and research institutions, with a Psychophysical Performance Program service for athletes and executives.
Is BioTekna a public or private company?
BioTekna is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was BioTekna founded?
BioTekna was founded in 1996. It employs 11 to 50 people.
Where is BioTekna based?
BioTekna is headquartered in Marcon, Italy, in the Europe region.
How does BioTekna make money?
Four revenue lines are on record. Medical Devices are the primary driver. The others are software Platform (BioTekna Plus), professional Training and Education and food Supplements (Melcalin).
Who are BioTekna's main competitors?
Emerging players on record are Whoop, Biopac Systems Inc. and Oura. Direct peers are InBody, HeartMath, Thought Technology Ltd. and Mind Media BV. Broad incumbents are Polar Electro, Tanita and Garmin.
Does BioTekna have an API?
No public API is recorded for BioTekna.